NICE supports use of asthma smartinhaler

The National Institute for Health and Care Excellence has published a Medtech Innovation Briefing recognising that Adherium’s Smartinhaler technology is more effective in improving adherence to asthma medication than current NHS practice.

Adherium says that five randomised controlled trials in the UK, Australia and New Zealand, involving a total of 589 people with asthma who used Smartinhaler in a community setting, showed that the device beat the standard of care in improving adherence to therapy.

Click here to read the full article.